Ethylamine

Ethylamine

SCHEMBL2885890

CCCNCCC.CCN

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
ALDH1A1 P00352 2/20 0.44
CA12 O43570 5/20 0.44
CA6 P23280 5/20 0.44
CA7 P43166 5/20 0.44
CA9 Q16790 5/20 0.44
CA14 Q9ULX7 5/20 0.44
CA5B Q9Y2D0 5/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
RECQL P46063 2/20 0.44
CA2 P00918 4/20 0.41
CA4 P22748 4/20 0.41
CA5A P35218 4/20 0.41
CA3 P07451 3/20 0.41
ALOX15 P16050 3/20 0.41
LMNA P02545 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CA1 P00915 2/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylamine SCHEMBL258912 0.89 CA12 (0.50) TSHRALDH1A1CA12CA6CA7
Methylamine SCHEMBL352966 0.88
SCHEMBL17626634 0.88 TSHR (0.53) TSHRALDH1A1CA12CA6CA7
SCHEMBL15445 0.88
SCHEMBL254034 0.86
SCHEMBL7184374 0.84
Propane SCHEMBL20526066 0.84 TSHR (0.50) TSHRALDH1A1CA12CA6CA7
SCHEMBL21176007 0.84
Bromide SCHEMBL3468246 0.84
SCHEMBL1003894 0.84 TSHR (0.50) TSHRALDH1A1CA12CA6CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4605740-A Process for the production of N-substituted acrylic acid amides CHEMISCHE FABRIK STOCKHAUSEN GMBH (DE) 1986-08-12 US claimed
US-20250122418-A1 Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds CLARIANT INT LTD (CH) 2025-04-17 US disclosed
US-12129427-B2 Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary alkyl ammonium compounds CLARIANT INTERNATIONAL LTD (CH) 2024-10-29 US disclosed
US-11898091-B2 Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary benzyl ammonium compounds CLARIANT INTERNATIONAL LTD (CH) 2024-02-13 US disclosed
US-11753577-B2 Method for inhibiting gas hydrate blockage in oil and gas pipelines CLARIANT INTERNATIONAL LTD. (CH) 2023-09-12 US disclosed
US-11753576-B2 Method for inhibiting gas hydrate blockage in oil and gas pipelines CLARIANT INTERNATIONAL LTD. (CH) 2023-09-12 US disclosed
EP-4073199-A1 SYNERGISTIC BLENDS OF ANTI-AGGLOMERANT GAS HYDRATE INHIBITORS WITH QUATERNARY BENZYL AMMONIUM COMPOUNDS Clariant International Ltd (CH) 2022-10-19 EP disclosed
EP-4073195-A1 SYNERGISTIC BLENDS OF ANTI-AGGLOMERANT GAS HYDRATE INHIBITORS WITH QUATERNARY ALKYL AMMONIUM COMPOUNDS Clariant International Ltd (CH) 2022-10-19 EP disclosed
EP-3702413-B1 PIGMENT DISPERSING AGENT, PIGMENT COMPOSITION, AND PIGMENT COLORING AGENT DAINICHISEIKA COLOR CHEM (JP) 2022-07-20 EP disclosed
EP-3864108-B1 UNSYMMETRICALLY SUBSTITUTED DICARBOXYLIC ACID DIAMIDO AMMONIUM SALTS AND THEIR USE FOR GAS HYDRATE ANTI-AGGLOMERATION CLARIANT INT LTD (CH) 2022-06-15 EP disclosed
US-5635552-A MIXTURES OF PIGMENT, DISPERSANT, WATER-BASED RESIN AND WATER SOLUBLE SOLVENT, FOR COATINGS, INKS TOYO INK MANUFACTURING CO., LTD. (JP) 1997-06-03 US disclosed
EP-0710706-A2 Method for dispersing pigment and water-based pigment dispersion TOYO INK MANUFACTURING CO., LTD. (JP) 1996-05-08 EP disclosed
US-5360564-A Hydrogenated star polymers SHELL OIL COMPANY (US) 1994-11-01 US disclosed
EP-0219706-B1 N,N-DIALKYLAMINOALKYL-HEXAHYDRO-5-OXO-1H-PYRROLIZINE-3-CARBOXAMIDES WARNER-LAMBERT COMPANY (US) 1989-06-21 EP disclosed
US-4724235-A N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia A. H. ROBINS COMPANY, INCORPORATED (US) 1988-02-09 US disclosed
EP-0219706-A1 N,N-dialkylaminoalkyl-hexahydro-5-oxo-1H-pyrrolizine-3-carboxamides WARNER-LAMBERT COMPANY (US) 1987-04-29 EP disclosed
US-4638006-A Amnesia reversal with N,N-dialkylaminoalkyl-hexahydro-5-oxo 1H-pyrrolizine-3-carboxamides WARNER LAMBERT COMPANY (US) 1987-01-20 US disclosed
EP-0197411-A2 Shear resistant cationic latex THE GLIDDEN COMPANY (US) 1986-10-15 EP disclosed
US-4605740-A Process for the production of N-substituted acrylic acid amides CHEMISCHE FABRIK STOCKHAUSEN GMBH (DE) 1986-08-12 US disclosed
US-4597902-A TREATMENT OF CARDIAC ARRHYTHMIAS A. H. ROBINS COMPANY, INCORPORATED (US) 1986-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12129427-B2 Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary alkyl ammonium compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RCC1, MTDH TSHR 3842/4885ALDH1A1 3129/4885CA12 1066/4885
US-11898091-B2 Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary benzyl ammonium compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RCC1, AQP1 TSHR 3814/4885ALDH1A1 3641/4885CA12 994/4885
US-20250122418-A1 Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDHD5, AQP1 TSHR 4317/4885ALDH1A1 3650/4885CA12 466/4885
US-11753576-B2 Method for inhibiting gas hydrate blockage in oil and gas pipelines H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, FFAR2, AQP1 TSHR 1937/4885ALDH1A1 2569/4885CA12 1632/4885
US-11753577-B2 Method for inhibiting gas hydrate blockage in oil and gas pipelines H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AQP1, FASN TSHR 2165/4885ALDH1A1 1166/4885CA12 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.